JP2023088988A5 - - Google Patents

Download PDF

Info

Publication number
JP2023088988A5
JP2023088988A5 JP2023045166A JP2023045166A JP2023088988A5 JP 2023088988 A5 JP2023088988 A5 JP 2023088988A5 JP 2023045166 A JP2023045166 A JP 2023045166A JP 2023045166 A JP2023045166 A JP 2023045166A JP 2023088988 A5 JP2023088988 A5 JP 2023088988A5
Authority
JP
Japan
Prior art keywords
peg
acid
formulation
formulation according
castor oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023045166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023088988A (ja
Filing date
Publication date
Priority claimed from JP2019569659A external-priority patent/JP2020509095A/ja
Application filed filed Critical
Publication of JP2023088988A publication Critical patent/JP2023088988A/ja
Publication of JP2023088988A5 publication Critical patent/JP2023088988A5/ja
Pending legal-status Critical Current

Links

JP2023045166A 2017-03-03 2023-03-22 改善された安定性を有する製剤 Pending JP2023088988A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762466955P 2017-03-03 2017-03-03
US62/466,955 2017-03-03
JP2019569659A JP2020509095A (ja) 2017-03-03 2018-03-02 改善された安定性を有する製剤
PCT/US2018/020797 WO2018161054A1 (en) 2017-03-03 2018-03-02 Formulations with improved stability

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019569659A Division JP2020509095A (ja) 2017-03-03 2018-03-02 改善された安定性を有する製剤

Publications (2)

Publication Number Publication Date
JP2023088988A JP2023088988A (ja) 2023-06-27
JP2023088988A5 true JP2023088988A5 (cg-RX-API-DMAC7.html) 2023-11-07

Family

ID=61692107

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019569659A Pending JP2020509095A (ja) 2017-03-03 2018-03-02 改善された安定性を有する製剤
JP2023045166A Pending JP2023088988A (ja) 2017-03-03 2023-03-22 改善された安定性を有する製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019569659A Pending JP2020509095A (ja) 2017-03-03 2018-03-02 改善された安定性を有する製剤

Country Status (10)

Country Link
US (2) US11629118B2 (cg-RX-API-DMAC7.html)
EP (1) EP3589280B1 (cg-RX-API-DMAC7.html)
JP (2) JP2020509095A (cg-RX-API-DMAC7.html)
KR (2) KR102641778B1 (cg-RX-API-DMAC7.html)
CN (2) CN110494415A (cg-RX-API-DMAC7.html)
AU (1) AU2018226879B2 (cg-RX-API-DMAC7.html)
CA (1) CA3054948C (cg-RX-API-DMAC7.html)
ES (1) ES2975417T3 (cg-RX-API-DMAC7.html)
MX (1) MX394833B (cg-RX-API-DMAC7.html)
WO (1) WO2018161054A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2975417T3 (es) * 2017-03-03 2024-07-05 Inspirna Inc Formulaciones con estabilidad mejorada
EP3713575A4 (en) 2017-11-21 2021-08-25 Rgenix, Inc. POLYMORPHS AND THEIR USES
JP7689964B2 (ja) 2019-12-13 2025-06-09 インスピルナ,インコーポレーテッド 金属塩及びその使用
AU2022248850A1 (en) 2021-03-27 2023-11-09 TRx Biosciences Limited Compositions having improved bioavailability of therapeutics
AU2023233811A1 (en) * 2022-03-14 2024-09-19 TRx Biosciences Limited Compositions having improved bioavailability of therapeutics and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680749A (en) 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
US3102078A (en) 1961-01-13 1963-08-27 Eastman Kodak Co Water-dispersible vitamin preparations
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6884060B2 (en) 2001-11-02 2005-04-26 R.P. Scherer Technologies, Inc. Apparatus for manufacturing encapsulated products
AU2003226094A1 (en) 2002-03-27 2003-10-13 Smithkline Beecham Corporation Compounds and methods
JP2005521721A (ja) 2002-03-27 2005-07-21 スミスクライン・ビーチャム・コーポレイション 酸およびエステル化合物ならびにその使用方法
US7323494B2 (en) 2002-03-27 2008-01-29 Smithkline Beecham Corporation Compounds and methods
EP1497270A4 (en) 2002-03-27 2006-01-04 Smithkline Beecham Corp AMID COMPOUNDS AND METHOD FOR THEIR USE
US20040219274A1 (en) 2003-04-29 2004-11-04 Cook Phillip Michael Beverages containing water-soluble vitamin E
KR20070072888A (ko) * 2004-10-25 2007-07-06 니뽄 다바코 산교 가부시키가이샤 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
US8231896B2 (en) 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
CN101232871A (zh) 2005-08-03 2008-07-30 伊士曼化工公司 生育酚聚乙二醇琥珀酸酯粉末及其制备方法
WO2014028461A2 (en) * 2012-08-13 2014-02-20 The Rockefeller University Treatment and diagnosis of melanoma
AU2015204572B2 (en) * 2014-01-10 2020-07-30 Inspirna, Inc. LXR agonists and uses thereof
WO2016100619A2 (en) * 2014-12-17 2016-06-23 Rgenix, Inc. Treatment and diagnosis of cancer
ES2975417T3 (es) * 2017-03-03 2024-07-05 Inspirna Inc Formulaciones con estabilidad mejorada

Similar Documents

Publication Publication Date Title
JP2020509095A5 (cg-RX-API-DMAC7.html)
JP6697779B2 (ja) カルシフェジオール軟カプセル剤
US20250188018A1 (en) Formulations with improved stability
US9895367B2 (en) Formulation comprising phenylaminopyrimidine derivative as active agent
US20230398111A1 (en) Oral formulations of nintedanib and method of manufacturing thereof
KR20220161356A (ko) 자발적 수용이 개선된 조성물
JP5897756B2 (ja) ロキソプロフェンナトリウム含有軟カプセル用内容物、及び、それを含有する軟カプセル製剤
HK40018941A (en) Formulations with improved stability
HK40018941B (en) Formulations with improved stability